A botanical supplement startup founder has seen business explode after impressing TV show ‘dragon’ investors with her scientific and personal knowledge of how hormones impact the skin.
Specially selected strains of lactobacilli may positively shift the skin microbiome and reduce acne lesions, says a new study from Belgium that deepens our knowledge of skin microbiome modulation.
Sanofi is to acquire Origimm Biotechnology in a move that gives the pharma giants a candidate to develop a first-in-class acne vaccine, which targets the skin microbiome and bacterial antigens that cause the skin condition.
British pharma company GlaxoSmithKline (GSK) are to pair up with Eligo Bioscience in a deal potentially worth €185m ($224m) that sees the firms target the microbiome to reduce the risk of developing acne.